Takeda Names Kim New CEO As It Reports Solid Q3

First Woman Head Of Major Japanese Pharma

Leading Japanese pharma firm names first ever woman chief exec as it reports a jump in operating profit in the fiscal nine months, led by Entyvio.

Julie Kim set to succeed Christophe Weber as Takeda CEO next year (Shutterstock)

Julie Kim, currently president of Takeda’s US Business Unit, has been named CEO-elect of the major Japanese firm, setting the stage for her to replace Christophe Weber in June 2026 when he retires.

Kim was unanimously appointed by the board after what the company said was a “thorough and exemplary” multi-year succession process that looked at “a strong pool” of both internal and external candidates

More from Leadership

More from Focus On Asia